Ongoing direct oral anticoagulant use not associated with reduced risk of severe COVID-19
Prognosis would not be modified by early outpatient DOAC initiation as per Journal of Internal Medicine.
“Identified as a key feature of severe COVID-19, large focus has been put on managing hypercoagulability in hospitalized patients, with interim guidelines supportive of anticoagulation,” wrote researchers led by Benjamin Flam, MD, Karolinska…
Read More...